{"transactions":[{"id":1323957,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-21T01:44:45.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":56525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":56525,"derivative":{"exercise_price":2.29,"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":56525},"source":{"system":"sec-edgar","filing":"0001415889-24-030003","document":"form4-12212024_011241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030003/form4-12212024_011241.xml","form_type":"4"}},{"id":1323956,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-21T01:44:45.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":41650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 25% of the RSUs vest on August 1, 2025, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter."}],"balance_after":82452,"source":{"system":"sec-edgar","filing":"0001415889-24-030003","document":"form4-12212024_011241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030003/form4-12212024_011241.xml","form_type":"4"}},{"id":1326429,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:35:10.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":2103,"price":2.34,"value":4921.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,477 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2024."}],"balance_after":40802,"source":{"system":"sec-edgar","filing":"0001415889-24-029744","document":"form4-12182024_041208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924029744/form4-12182024_041208.xml","form_type":"4"}},{"id":1458224,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-08T20:30:18.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":3852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents RSUs that are fully vested as of March 14, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,106 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2024."}],"balance_after":38428,"source":{"system":"sec-edgar","filing":"0001415889-24-019346","document":"form4-07082024_040715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924019346/form4-07082024_040715.xml","form_type":"4"}},{"id":1458223,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-08T20:30:18.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":1220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024."}],"balance_after":32470,"source":{"system":"sec-edgar","filing":"0001415889-24-019346","document":"form4-07082024_040715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924019346/form4-07082024_040715.xml","form_type":"4"}},{"id":1486423,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Warrant (Right to Buy)","published_at":"2024-06-08T01:40:05.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":31250,"derivative":{"exercise_price":5.25,"exercise_date":"2024-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001415889-24-016097","document":"form4-06072024_090601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016097/form4-06072024_090601.xml","form_type":"4"}},{"id":1486422,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-08T01:40:05.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":31250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001415889-24-016097","document":"form4-06072024_090601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016097/form4-06072024_090601.xml","form_type":"4"}},{"id":1782790,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":84860,"kind":"person","name":"Zak Lourie S.","position":1,"cik":"0001991207","reported_name":"Zak Lourie S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-12T20:19:27.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on September 11, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":150000,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-049093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049093/doc4.xml","form_type":"4"}}]}